Potent Antipneumococcal Activity of Gemifloxacin Is Associated with Dual Targeting of Gyrase and Topoisomerase IV, an In Vivo Target Preference for Gyrase, and Enhanced Stabilization of Cleavable Complexes In Vitro

We investigated the roles of DNA gyrase and topoisomerase IV in determining the susceptibility of Streptococcus pneumoniae to gemifloxacin, a novel fluoroquinolone which is under development as an antipneumococcal drug. Gemifloxacin displayed potent activity against S. pneumoniae 7785 (MIC, 0.06 μg/...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Antimicrob Agents Chemother
المؤلفون الرئيسيون:	Heaton, Victoria J., Ambler, Jane E., Fisher, L. Mark
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 2000
الموضوعات:	Mechanisms of Action: Physiological Effects
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC101612/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11036032/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.11.3112-3117.2000
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!